The company had consistently failed to comply with good manufacturing practice requirements. Many drugs were misbranded, were of unknown origin, and had questionable handling and storage.
In July 2003, FDA seized more than 4귔 bottles of prescription drugs that were being repackaged by Local Repack in conjunction with an investigation into counterfeit Lipitor tablets.
The latest seizure included bottles ranging in size from 5ꯠ- to 10ꯠ-count bottles of bulk product with foreign language labels, to 90-count bottles of foreign product that had been repacked and labeled in English.
